Fulminant Myocarditis Secondary to Cardiac T-Cell Lymphoma

Yifei Wang, Huan Li, Shanquan Gao, Y W Liu, Lihong Li, Zhiwei Han, Yilu Wang, Ping Zhang, Hongfang Yin, Rong HeJACC 2025 · DOI

TL;DR

This case report highlights a rare and aggressive presentation of cardiac T-cell lymphoma leading to fulminant myocarditis. The paper emphasizes the critical role of early myocardial biopsy in diagnosing such rapidly deteriorating cardiac conditions, as conventional treatments proved ineffective.

What Problem Does This Paper Address?

The paper addresses the diagnostic challenge posed by rare and aggressive malignancies that can present with vague, non-specific symptoms, leading to delayed diagnosis and poor outcomes. Specifically, it focuses on cardiac T-cell lymphoma, a malignancy that can manifest as fulminant myocarditis, a severe and rapidly progressing inflammation of the heart muscle. The problem lies in the difficulty of distinguishing this specific type of lymphoma-induced myocarditis from other causes of myocarditis, especially when symptoms are ambiguous and the patient's condition deteriorates quickly. This delay in diagnosis hinders timely and effective intervention, often leading to fatal consequences.

Methods

The study is a case report detailing the clinical course of a single patient. The diagnostic approach involved:

  • Clinical Examination and History: Standard patient history taking and physical examination.
  • Laboratory Investigations: Comprehensive blood tests including troponin, complete blood count, creatinine, eosinophil count, LDH, and IgE levels.
  • Electrocardiography (ECG): To assess electrical activity of the heart.
  • Echocardiography: To evaluate cardiac structure and function, including left ventricular ejection fraction (LVEF).
  • Coronary Angiography: To assess for coronary artery disease.
  • Holter Monitoring and Brain MRI: To rule out other causes of syncope.
  • Cardiac Magnetic Resonance (CMR): To visualize myocardial edema and assess cardiac function.
  • Myocardial Biopsy: This was the key diagnostic intervention, performed on both the interventricular septum and the basal myocardium. Biopsies were analyzed using:
  • Hematoxylin and Eosin (HE) staining: For general tissue morphology.
  • Immunohistochemistry: To identify specific cell markers (e.g., CD3, CD4, CD5, CD8, CD30, granzyme B, T-cell intracellular antigen-1).
  • Next-Generation Sequencing (NGS): To detect microbial DNA.
  • Ki-67 Proliferation Index: To assess cell growth rate.
  • T-cell Receptor Gene Rearrangement Testing: To confirm clonality of T-cells.

The management involved supportive care, including extracorporeal membrane oxygenation (ECMO) and intra-aortic balloon pump, along with immunomodulatory therapies (steroids and immunoglobulin) and dexamethasone.

Datasets

Not discussed in the paper. This is a case report focusing on a single patient's clinical journey and diagnostic investigations.

Key Insights and Ideas

  • Myocardial Biopsy is Paramount: The paper strongly advocates for early myocardial biopsy in cases of unexplained, rapidly deteriorating myocarditis. It was the definitive diagnostic tool that revealed the underlying cardiac T-cell lymphoma.
  • Vague Symptoms Mask Aggressive Disease: Cardiac T-cell lymphoma can present with non-specific symptoms like syncope, anorexia, and abdominal discomfort, masking its aggressive nature and delaying diagnosis.
  • Fulminant Myocarditis as a Presentation: This case underscores that fulminant myocarditis can be a direct consequence of cardiac T-cell lymphoma, rather than a separate, co-existing condition.
  • Hypereosinophilia as a Clue: While not meeting the criteria for hypereosinophilic syndrome, the initial hypereosinophilia served as an important, albeit initially misleading, clue that pointed towards an underlying inflammatory or neoplastic process. It's suggested to be a paraneoplastic manifestation.
  • Limited Efficacy of Conventional Therapies: Standard treatments for myocarditis (steroids, immunoglobulin) were largely ineffective, highlighting the need to address the underlying lymphoma.
  • Diagnostic Delays are Detrimental: The paper implicitly suggests that delays in diagnosis, due to the complexity and rarity of the condition, significantly impacted the patient's prognosis.

Key Results

  • A 73-year-old male presented with syncope and abdominal discomfort, later developing hypereosinophilia and rapidly progressing to fulminant myocarditis.
  • Despite initial treatment with antibiotics, methylprednisolone, and immunoglobulin, cardiac function continued to decline, necessitating ECMO and intra-aortic balloon pump support.
  • Myocardial biopsy confirmed cardiac T-cell lymphoma with lymphocytic infiltration, characterized by CD3-positive lymphocytes and a high Ki-67 proliferation index (85%).
  • The patient's condition ultimately deteriorated, leading to palliative care and death on the 19th day of hospitalization, despite aggressive interventions.

Limitations and Future Work

  • Limitations:
    • Single Case Report: Findings are based on one patient, limiting generalizability.
  • Diagnostic Delays: The rapid progression and initial ambiguity of symptoms led to delays in definitive diagnosis, preventing comprehensive staging of the lymphoma (e.g., via PET-CT, bone marrow aspiration).
  • Limited Imaging: Contrast-enhanced CMR was not performed due to patient intolerance, and global longitudinal strain assessment was limited by bedside echocardiography capabilities.
  • Unclear Eosinophil Role: It remains unclear whether eosinophilic myocarditis was present at the onset, as biopsy after corticosteroid treatment showed only a few eosinophils.
  • Future Work:
    • The paper implicitly calls for increased awareness of cardiac T-cell lymphoma as a cause of fulminant myocarditis.
  • It highlights the need for developing more rapid and accurate diagnostic tools for rare cardiac malignancies.
  • Further research into the mechanisms by which T-cell lymphoma induces myocarditis and the potential for earlier targeted therapies would be beneficial.
  • The authors suggest that unexplained hypereosinophilia should prompt more aggressive diagnostic investigations for underlying neoplastic processes.

Summary updated

Abstract

Early myocardial biopsy is crucial in cases of unexplained myocarditis with rapid deterioration. Cardiac T-cell lymphoma is a rare and aggressive condition that can rapidly progress to fulminant myocarditis in certain cases, necessitating early diagnosis and intervention.
BibTeX
@inproceedings{wang2025fulminant,
  author = {Yifei Wang and Huan Li and Shanquan Gao and Y W Liu and Lihong Li and Zhiwei Han and Yilu Wang and Ping Zhang and Hongfang Yin and Rong He and Hongfang Yin and Rong He},
  title = {{Fulminant Myocarditis Secondary to Cardiac T-Cell Lymphoma}},
  booktitle = {JACC},
  year = {2025},
  doi = {10.1016/j.jaccas.2025.104743},
}
Figure